Michael Tadao Inouye/LinkedIn, David Hunter/ariadnelabs.org
Sep 26, 2026, 15:42
Michael Tadao Inouye: The Next Frontier in Genomic Population Health
Michael Tadao Inouye, Director of Postgraduate Education (Research), Strand Lead – Molecular Informatics Resources and Tools at University of Cambridge, shared a post on LinkedIn about a recent article he and David J. Hunter co-authored, published in NEJM, adding:
“It’s been a long time coming but delighted to see that the NEJM Group review from David Hunter and me is out!
‘Clinical Uses of Common Genetic Variants Associated with Common Diseases.’
The next 10 years will be a very exciting time for genomic population health.”
Title: Clinical Uses of Common Genetic Variants Associated with Common Diseases
Authors: David J. Hunter, Michael Inouye
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?